- March 6-7, 2022 (deadline for submissions is end of day Wednesday, January 5, 2022) – CANCELLED
- June 5-6, 2022 (deadline for submissions is end of day Wednesday, April 6, 2022)
- September 18-19, 2022 (deadline for submissions is end of day Wednesday, July 20, 2022)
- December 4-5, 2022 (deadline for submissions is end of day Wednesday, October 5, 2022)
NAPRA must receive a digital copy of the submission documents in PDF format, along with payment of the drug scheduling fee via electronic funds transfer (EFT) at least 60 days before the NDSAC meeting is scheduled. In order to ensure the drug scheduling fee is received on time, please contact the NDSAC secretariat at least three (3) weeks prior to the submission deadline to request an invoice (or other EFT information that the applicant requires).
NAPRA typically reviews drug scheduling applications in the order in which they are received at the NDSAC Secretariat along with applicable fees. NAPRA reserves the authority to change the review sequence if it is determined to be in the public interest to do so. Any decision to modify the usual review sequence is determined jointly by the Chair of NDSAC and the Executive Director of NAPRA. Meeting the posted deadline for submission does not, therefore, guarantee that the application will be reviewed at the corresponding NDSAC meeting. There is a limit of two submissions reviewed at any given meeting.
Exclude from search: No